Massive suicidal ingestion of caffeine: a case report with investigation of the cardiovascular effect/concentration relationships

Clin Toxicol (Phila). 2021 Oct;59(10):937-941. doi: 10.1080/15563650.2021.1891243. Epub 2021 Mar 10.

Abstract

Background: Caffeine poisoning may cause life-threatening arrhythmias and hemodynamic failure. We aimed to investigate the toxicokinetics (TK), toxicodynamics (TD) and TK/TD relationships of caffeine in a case of poisoning.

Case report: A 47-year-old male ingested pure anhydrous caffeine powder (70 g) in a suicide attempt. He developed agitation, tachycardia, and two episodes of ventricular fibrillation treated with defibrillation and tracheal intubation. He was successfully managed using intravenous infusions of esmolol and norepinephrine.

Methods: We modelled the time-course of plasma caffeine concentration (TK study using online liquid chromatography-tandem mass spectrometry), the time-course of blood lactate concentration and infusion rates of esmolol and norepinephrine (TD studies) and the TK/TD relationships.

Results: Caffeine TK was of first-order peaking at 258 mg/L with an elimination half-life of 46.2 h and clearance of 2.2 L/h. Caffeine-related effects on blood lactate (peak, 10 mmol/L at 1.25 h postingestion) were described by a Bateman-type equation (formation rate, 0.05 mmol/mg.h; elimination rate, 0.9 mmol/mg.h). Esmolol and norepinephrine infusion rates to reverse caffeine-related cardiovascular effects (peaks at 51-h postingestion) fitted well with a sigmoidal Emax model (EC50, 180.0 and 225.9 mg/L, respectively; Hill coefficient, 10.0).

Conclusion: Massive caffeine ingestion is characterized by prolonged caffeine elimination. TK/TD relationships are helpful to quantify caffeine-related catecholaminergic effects.

Keywords: Caffeine; esmolol; norepinephrine; poisoning; toxicodynamics; toxicokinetics.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Adrenergic alpha-Agonists / administration & dosage
  • Adrenergic beta-1 Receptor Antagonists / administration & dosage
  • Caffeine / administration & dosage
  • Caffeine / pharmacokinetics
  • Caffeine / poisoning*
  • Cardiotoxicity
  • Central Nervous System Stimulants / administration & dosage
  • Central Nervous System Stimulants / pharmacokinetics
  • Central Nervous System Stimulants / poisoning*
  • Electric Countershock
  • Half-Life
  • Heart Rate / drug effects*
  • Humans
  • Hyperlactatemia / chemically induced
  • Infusions, Intravenous
  • Intubation, Intratracheal
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Norepinephrine / administration & dosage
  • Powders
  • Propanolamines / administration & dosage
  • Suicide, Attempted*
  • Tachycardia / chemically induced*
  • Tachycardia / diagnosis
  • Tachycardia / physiopathology
  • Tachycardia / therapy
  • Treatment Outcome
  • Ventricular Fibrillation / chemically induced*
  • Ventricular Fibrillation / diagnosis
  • Ventricular Fibrillation / physiopathology
  • Ventricular Fibrillation / therapy

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic beta-1 Receptor Antagonists
  • Central Nervous System Stimulants
  • Powders
  • Propanolamines
  • Caffeine
  • esmolol
  • Norepinephrine